Abstract

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated. Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown that salbutamol was more effective than ipratropium in asthma treatment. Recently, tiotropium has been studied in asthma, when added to low-dose inhaled corticosteroids in unselected moderate asthmatics or in patients with uncontrolled asthma, or patients with chronic obstructive pulmonary disease and history of asthma. Later, studies on patients with Arg/Arg β(2)-receptor polymorphism demonstrated a similar efficacy of tiotropium in comparison with salmeterol when both were added to low-dose inhaled corticosteroids. Further long-term studies are currently in progress, for the evaluation of the efficacy of tiotropium on clinical asthma control, and on the rate and severity of asthma exacerbations, as well as the potential modification of inflammatory mechanisms and varying efficacy in specific asthma phenotypes (such as smoking asthmatics).

Links

Publisher Full Text

Publisher Full Text

Authors

Novelli F, Malagrinò L, Dente FL, Paggiaro P

Institution

Cardio-Thoracic and Vascular Department, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy.

Source

Expert review of respiratory medicine 6:3 2012 Jun pg 309-19

MeSH

Adrenal Cortex Hormones
Animals
Asthma
Bronchoconstriction
Bronchodilator Agents
Cholinergic Antagonists
Drug Therapy, Combination
Humans
Lung
Phenotype
Treatment Outcome

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22788945